Search for: "Tough v. Ives" Results 1 - 20 of 156
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2022, 4:15 am by Jonathan Stroud
The Board filings were dominated by tech-versus-long-running-NPE suits, with a few competitor-competitor challenges (e.g., Vivint v. [read post]
29 Jul 2022, 4:15 am by Jonathan Stroud
The Board filings were dominated by tech-versus-long-running-NPE suits, with a few competitor-competitor challenges (e.g., Vivint v. [read post]
1 Apr 2018, 10:47 am by David Pozen
  Whether or not this conclusion extends to those who deny even a generalized version of the fixation thesis depends on whether such persons are deemed to have the capacity for rational thought.Part IV (pp. 258-305) tells the story of originalism’s theoretical development. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Jun 2010, 5:35 am
(Spicy IP) Wellbutrin (Bupropion) – US: Pennsylvania District Court decision signals a new turn in the generic drug preemption debate; a tough pill to swallow for the generic industry: In re Budeprion XL Marketing & Sales Litigation (FDA Law Blog)   [read post]